Insider · CIK 0001275012

GARRITY THOMAS J

Reports to the SEC for 1 company · EWING, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001275012

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-05-24	ANTARES PHARMA, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−224K sh	$5.60	−$1.26M	0
2022-05-24	ANTARES PHARMA, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−25.5K sh	$5.60	−$143K	0
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−61.9K sh	—	—	0
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−99.4K sh	—	—	0
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−80.3K sh	—	—	0
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−76.5K sh	—	—	0
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−46.7K sh	—	—	0
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−58.2K sh	—	—	0
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−48.5K sh	—	—	0
2021-06-10	ANTARES PHARMA, INC.A Award	Director	AAward	+25.5K sh	$4.42	+$112K	249,858
2021-06-10	ANTARES PHARMA, INC.Stock Option (right to buy)A Award	Director	AAward	+48.5K sh	—	—	48,542
2021-03-11	ANTARES PHARMA, INC.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$1.12	+$56K	274,406
2021-03-11	ANTARES PHARMA, INC.S Sale	Director	SSale	−50K sh	$4.28	−$214K	224,406
2021-03-11	ANTARES PHARMA, INC.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	0
2021-02-11	ANTARES PHARMA, INC.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$1.12	+$56K	274,406
2021-02-11	ANTARES PHARMA, INC.S Sale	Director	SSale	−50K sh	$4.62	−$231K	224,406
2021-02-11	ANTARES PHARMA, INC.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	0
2021-01-11	ANTARES PHARMA, INC.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$2.24	+$44.8K	244,406
2021-01-11	ANTARES PHARMA, INC.S Sale	Director	SSale	−20K sh	$4.07	−$81.4K	224,406
2021-01-11	ANTARES PHARMA, INC.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$1.12	+$56K	274,406
2021-01-11	ANTARES PHARMA, INC.S Sale	Director	SSale	−50K sh	$4.05	−$203K	224,406
2021-01-11	ANTARES PHARMA, INC.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2021-01-11	ANTARES PHARMA, INC.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	0
2020-06-11	ANTARES PHARMA, INC.A Award	Director	AAward	+30.2K sh	$2.73	+$82.5K	224,406
2020-06-11	ANTARES PHARMA, INC.Stock Option (right to buy)A Award	Director	AAward	+58.2K sh	—	—	58,246
2019-12-09	ANTARES PHARMA, INC.M Exercise/Conversion	Director	MExercise/Conversion	+40K sh	$1.60	+$64K	234,186
2019-12-09	ANTARES PHARMA, INC.S Sale	Director	SSale	−40K sh	$4.58	−$183K	194,186
2019-12-09	ANTARES PHARMA, INC.M Exercise/Conversion	Director	MExercise/Conversion	+40K sh	$1.66	+$66.4K	234,186
2019-12-09	ANTARES PHARMA, INC.S Sale	Director	SSale	−40K sh	$4.58	−$183K	194,186
2019-12-09	ANTARES PHARMA, INC.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−40K sh	—	—	0
2019-12-09	ANTARES PHARMA, INC.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−40K sh	—	—	0
2019-11-01	ANTARES PHARMA, INC.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$1.10	+$11K	194,186
2019-11-01	ANTARES PHARMA, INC.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2019-06-13	ANTARES PHARMA, INC.A Award	Director	AAward	+24K sh	$2.92	+$70K	184,186
2019-06-13	ANTARES PHARMA, INC.Stock Option (right to buy)A Award	Director	AAward	+46.7K sh	—	—	46,729
2019-05-01	ANTARES PHARMA, INC.M Exercise/Conversion	Director	MExercise/Conversion	+30K sh	$0.53	+$15.9K	190,213
2019-05-01	ANTARES PHARMA, INC.S Sale	Director	SSale	−30K sh	$2.67	−$80K	160,213
2019-05-01	ANTARES PHARMA, INC.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−30K sh	—	—	0
2018-06-08	ANTARES PHARMA, INC.Stock Option (right to buy)A Award	Director	AAward	+76.5K sh	—	—	76,548
2017-10-03	ANTARES PHARMA, INC.M Exercise/Conversion	Director	MExercise/Conversion	+30K sh	$0.85	+$25.5K	190,213
2017-10-03	ANTARES PHARMA, INC.S Sale	Director	SSale	−30K sh	$3.50	−$105K	160,213
2017-10-03	ANTARES PHARMA, INC.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−30K sh	—	—	0
2017-06-07	ANTARES PHARMA, INC.Stock Option (right to buy)A Award	Director	AAward	+80.3K sh	—	—	80,318
2017-03-31	ANTARES PHARMA, INC.M Exercise/Conversion	Director	MExercise/Conversion	+30K sh	$1.65	+$49.5K	190,213
2017-03-31	ANTARES PHARMA, INC.S Sale	Director	SSale	−30K sh	$2.91	−$87.3K	160,213
2017-03-31	ANTARES PHARMA, INC.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−30K sh	—	—	0
2016-06-02	ANTARES PHARMA, INC.Stock Option (right to buy)A Award	Director	AAward	+150K sh	—	—	150,000
2016-03-18	ANTARES PHARMA, INC.P Purchase	Director	PPurchase	+30K sh	$0.72	+$21.6K	160,213
2015-05-28	ANTARES PHARMA, INC.Stock option (right to buy)A Award	Director	AAward	+99.4K sh	—	—	99,395
2014-08-11	ANTARES PHARMA, INC.P Purchase	Director	PPurchase	+5,000 sh	$1.98	+$9,900	130,213

Recent filings

Accepted (ET)
May 264
GARRITY THOMAS J0000899243-22-019786
SEC(opens sec.gov)
Jun 144
GARRITY THOMAS J0001209191-21-040327
SEC(opens sec.gov)
Mar 124
GARRITY THOMAS J0001209191-21-020289
SEC(opens sec.gov)
Feb 124
GARRITY THOMAS J0001209191-21-010411
SEC(opens sec.gov)
Jan 134
GARRITY THOMAS J0001209191-21-003497
SEC(opens sec.gov)

Companies

ANTARES PHARMA, INC.Director

Address

C/O ANTARES PHARMA INC 250 PHILLIPS BLVD, SUITE 290

EWING, NJ, 08618